Exploring Factors Influencing Human Papillomavirus (HPV) Vaccine Uptake Among the (10- 14) Year Old Girls in Kiambu County, Kenya

References

[1] Arbyn, M., Weiderpass, E., Bruni, L., De Sanjosé, S., Saraiya, M., Ferlay, J., & Bray, F. (2020). Estimates of incidence and mortality of cervical cancer in 2018: A worldwide analysis. The Lancet Global Health, 8(2), e191–e203. https://doi.org/10.1016/S2214-109X(19)30482-6

[2] Bartlett, J. W., Harel, O., & Carpenter, J. R. (2015). Asymptotically Unbiased Estimation of Exposure Odds Ratios in Complete Records Logistic Regression. American Journal of Epidemiology, 182(8), 730–736. https://doi.org/10.1093/aje/kwv114

[3] Cartmell, K. B., Young-Pierce, J., McGue, S., Alberg, A. J., Luque, J. S., Zubizarreta, M., & Brandt, H. M. (2018). Barriers, facilitators, and potential strategies for increasing HPV vaccination: A statewide assessment to inform action. Papillomavirus Research, 5, 21–31. https://doi.org/10.1016/j.pvr.2017.11.003

[4] Clarke, V., & Braun, V. (2017). Thematic analysis. The Journal of Positive Psychology, 12(3), 297–298. https://doi.org/10.1080/17439760.2016.1262613

[5] Clifford, G. M., Smith, J. S., Plummer, M., Muñoz, N., & Franceschi, S. (2019). Human papillomavirus types in invasive cervical cancer worldwide: A meta-analysis. British Journal of Cancer, 88(1), 63–73. https://doi.org/10.1038/sj.bjc.6600688

[6] Cummings, C. A., Fisher, C. M., & Reilly-Chammat, R. (2021). Improving practice: Giving voice to the experiences of sexual health education teachers. Health Education Journal, 80(8), 897–907. https://doi.org/10.1177/00178969211029677

[7] De Villiers, E.-M., Fauquet, C., Broker, T. R., Bernard, H.-U., & Zur Hausen, H. (2019). Classification of papillomaviruses. Virology, 324(1), 17–27. https://doi.org/10.1016/j.virol.2004.03.033

[8] Deignan, C., Swartz, A., Cooper, S., & Colvin, C. J. (2021). Stakeholders’ Understandings of Human Papillomavirus (HPV) Vaccination in Sub-Saharan Africa: A Rapid Qualitative Systematic Review. Vaccines, 9(5), 496. https://doi.org/10.3390/vaccines9050496

[9] Dempsey, A. F., Zimet, G. D., Davis, R. L., & Koutsky, L. (2020). Factors That Are Associated With Parental Acceptance of Human Papillomavirus Vaccines: A Randomized Intervention Study of Written Information About HPV. Pediatrics, 117(5), 1486–1493. https://doi.org/10.1542/peds.2005-1381

[10] Denny, L., Adewole, I., Anorlu, R., Dreyer, G., Moodley, M., Smith, T., Snyman, L., Wiredu, E., Molijn, A., Quint, W., Ramakrishnan, G., & Schmidt, J. (2014). Human papillomavirus prevalence and type distribution in invasive cervical cancer in sub‐Saharan Africa. International Journal of Cancer, 134(6), 1389–1398. https://doi.org/10.1002/ijc.28425

[11] Ferlay, J., Soerjomataram, I., Dikshit, R., Eser, S., Mathers, C., Rebelo, M., Parkin, D. M., Forman, D., & Bray, F. (2018). Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012. International Journal of Cancer, 136(5). https://doi.org/10.1002/ijc.29210

[12] Gamaoun, R. (2018). Knowledge, awareness and acceptability of anti-HPV vaccine in the Arab states of the Middle East and North Africa Region: A systematic review. Eastern Mediterranean Health Journal, 24(6), 538–548. https://doi.org/10.26719/2018.24.6.538

[13] Gitonga, E., Iseme, R., Mutisya, R., & Kodhiambo, M. (2022). Cervical cancer knowledge, awareness, and related health behaviours amongst women of reproductive age in Kiambu County, Kenya: A cross-sectional study. Health Psychology and Behavioral Medicine, 10(1), 1056–1070. https://doi.org/10.1080/21642850.2022.2136184

[14] Jung, S. (2014). Stratified Fisher’s exact test and its sample size calculation. Biometrical Journal, 56(1), 129–140. https://doi.org/10.1002/bimj.201300048

[15] Karanja-Chege, C. M. (2022). HPV Vaccination in Kenya: The Challenges Faced and Strategies to Increase Uptake. Frontiers in Public Health, 10, 802947. https://doi.org/10.3389/fpubh.2022.802947

[16] Khan, Z. A., Ahmad, M., & Butt, S. (2019). Implementation of Lean Practices in Banks: A Qualitative Research. Independent Journal of Management & Production, 10(2), 489–498. https://doi.org/10.14807/ijmp.v10i2.862

[17] Kusakabe, M., Taguchi, A., Sone, K., Mori, M., & Osuga, Y. (2023). Carcinogenesis and management of human papillomavirus-associated cervical cancer. International Journal of Clinical Oncology, 28(8), 965–974. https://doi.org/10.1007/s10147-023-02337-7

[18] Lake, P., Fuzzell, L., Brownstein, N. C., Fontenot, H. B., Michel, A., McIntyre, M., Whitmer, A., Rossi, S. L., Perkins, R. B., & Vadaparampil, S. T. (2023). HPV vaccine recommendations by age: A survey of providers in federally qualified health centers. Human Vaccines & Immunotherapeutics, 19(1), 2181610. https://doi.org/10.1080/21645515.2023.2181610

[19] Muthoni, M. (2018). Socio-Demographic Characteristics Influencing Uptake of Screening for Cervical Cancer in Women Aged 18-49 Years in Imenti North Sub-county, Meru County, Kenya. Science Journal of Public Health, 4(2), 94. https://doi.org/10.11648/j.sjph.20160402.13

[20] Muthukrishnan, M., Loux, T., Shacham, E., Tiro, J. A., & Arnold, L. D. (2022). Barriers to human papillomavirus (HPV) vaccination among young adults, aged 18–35. Preventive Medicine Reports, 29, 101942. https://doi.org/10.1016/j.pmedr.2022.101942

[21] Newman, P. A., Logie, C. H., Lacombe-Duncan, A., Baiden, P., Tepjan, S., Rubincam, C., Doukas, N., & Asey, F. (2018). Parents’ uptake of human papillomavirus vaccines for their children: A systematic review and meta-analysis of observational studies. BMJ Open, 8(4), e019206. https://doi.org/10.1136/bmjopen-2017-019206

[22] Nguyen-Huu, N.-H., Thilly, N., Derrough, T., Sdona, E., Claudot, F., Pulcini, C., & Agrinier, N. (2020). Human papillomavirus vaccination coverage, policies, and practical implementation across Europe. Vaccine, 38(6), 1315–1331. https://doi.org/10.1016/j.vaccine.2019.11.081

[23] Onwuegbuzie, A. J., Leech, N. L., & University of Colorado Denver, Denver, CO, USA. (2019). RESEARCH methodology; ACQUISITION of data; EVALUATION research; DATA analysis. International Journal of Multiple Research Approaches, 11(2), 98–131. https://doi.org/10.29034/ijmra.v11n2editorial2

[24] Rivera, A. F., Dussault, J. M., Oudin Doglioni, D., Chyderiotis, S., Sicsic, J., Barret, A.-S., Raude, J., Gauchet, A., Gagneux-Brunon, A., Bruel, S., Michel, M., Le Duc-Banaszuk, A.-S., Thilly, N., & Mueller, J. E. (2024). Sociodemographic determinants of HPV vaccine awareness, uptake, and intention among parents of adolescents in France 2021-22. Human Vaccines & Immunotherapeutics, 20(1), 2381300. https://doi.org/10.1080/21645515.2024.2381300

[25] Sitaresmi, M. N., Rozanti, N. M., Simangunsong, L. B., & Wahab, A. (2020). Improvement of Parent’s awareness, knowledge, perception, and acceptability of human papillomavirus vaccination after a structured-educational intervention. BMC Public Health, 20(1), 1836. https://doi.org/10.1186/s12889-020-09962-1

[26] Taherdoost, H. (2017). Determining Sample Size; How to Calculate Survey Sample Size. 2.

[27] Umutesi, G., Oluoch, L., Weiner, B. J., Bukusi, E., Onono, M., Njoroge, B., Mecca, L., Ngure, K., Mugo, N. R., & Barnabas, R. V. (2023). HPV vaccination in Kenya: A study protocol to assess stakeholders’ perspectives on implementation drivers of HPV vaccination and the acceptability of the reduced dose strategy among providers. Frontiers in Health Services, 3, 1233923. https://doi.org/10.3389/frhs.2023.1233923

[28] Vermandere, H., Naanyu, V., Degomme, O., & Michielsen, K. (2018). Implementation of an HPV vaccination program in Eldoret, Kenya: Results from a qualitative assessment by key stakeholders. BMC Public Health, 15(1), 875. https://doi.org/10.1186/s12889-015-2219-y

[29] Villa, L. L., Sichero, L., Rahal, P., Caballero, O., Ferenczy, A., Rohan, T., & Franco, E. L. (2019). Molecular variants of human papillomavirus types 16 and 18 preferentially associated with cervical neoplasia. Journal of General Virology, 81(12), 2959–2968. https://doi.org/10.1099/0022-1317-81-12-2959

[30] Warui, L. W., Suleman, M. A., Makokha, F. W., & Kamita, M. (2021). Trend in Cancer Cases Diagnosed at Kiambu and Gatundu Level 5 Hospitals, Kiambu County Kenya between 2013 and 2017.

[31] Wilson, D. (2015). HIV Programs for Sex Workers: Lessons and Challenges for Developing and Delivering Programs. PLOS Medicine, 12(6), e1001808. https://doi.org/10.1371/journal.pmed.1001808

@article{1707508,
      author = {Wilta Kwamboka, Gladys Mokua, Osborn Tembu},
      title = {Exploring Factors Influencing Human Papillomavirus (HPV) Vaccine Uptake Among the (10- 14) Year Old Girls in Kiambu County, Kenya},
      journal = {Iconic Research And Engineering Journals},
      year = {2025},
      volume = {8},
      number = {9},
      pages = {1002-1016},
      issn = {2456-8880},
      url = {https://www.irejournals.com/formatedpaper/1707508.pdf},
      abstract = {Objective; This was a cross-sectional study whose objective was to explore the barriers and facilitators to human papillomavirus vaccine uptake among the (10- 14) year olds girls in Kiambu County 
Design; This was a cross-sectional mixed-method research design. 
Setting; Within Kiambu County in the 12 sub-counties; Githunguri, Kiambaa, Lari, Limuru, Kabete, Gatundu North, Gatundu South, Juja, Kikuyu, Thika town, Ruiru and Kiambu Town.  
Subjects; Parents of young girls aged between 10 to 14 years who were residents of Kiambu County 
Materials and Methods; Semi-structured questionnaires were used to capture data from a sample size of 358 participants from the12 sub-counties in Kiambu County. Qualitative data was purposively selected from the seven key informant interviews and two focus group discussions. Included were Aal the parents/guardians of 10-14-year-olds who gave consent to participate in the study.
Data management; Quantitative data was analyzed using SPSS ver. 21 and the qualitative data was analyzed using an ATLAS. ti. ver. 23 software. Descriptive statistics were measured using percentages, means, and standard deviation (SD), and presented on tables and charts. Logistic regression was performed to estimate the impact of predictor variables (institutional factors, provider factors, and barriers factors) on study outcomes. Throughout analysis ? < 0.05 was considered statistically significant at a 95% confidence interval. 
Results; A total of 358 questionnaires was analyzed which accounted for a 93% response rate in all parts of the 12 sub-counties in Kiambu with 238 (66%) females and 120 (34%) males. All the girls were 100% enrolled in school, while 53% of respondents had prior knowledge of the HPV vaccine, 43.3% were willing to vaccinate their daughters and 45% did not harbor the idea of contraction of human papillomavirus after vaccination. There was a statistically significant association between institutional factors and human papillomavirus vaccine uptake (p<0.001), the relationship between barriers and human papillomavirus vaccine uptake was statically significant (p< 0.004) as well as a statistically significant association between provider factors and the HPV vaccine (p< 0.005).  
Conclusions; Having vaccine ambassadors who remind caregivers of the HPV vaccine availability, positive feedback from victims of cervical cancer, and financial incentives were necessary influencing factors in prompting human papillomavirus vaccine uptake amongst teenage girls. Inadequate information, lack of provider communications or recommendations about human papillomavirus vaccines, and safety concerns on human papillomavirus vaccines proved to be barriers to human papillomavirus vaccine uptake.},
      keywords = {Human Papillomavirus, Vaccine Uptake, Cervical Cancer, Adolescent girls},
      month = {March},
  }